Alpine Global Management’s Instil Bio TIL Stock Holding History

Alpine Global Management’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,148	Closed	-$14K	–	394
2022 Q4	$14K	Buy	+1,148	New	+$56.7K	﹤0.01%	425

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Alpine Global Management's TIL Position: Q1 2023 in Review

Alpine Global Management sold out of Instil Bio (TIL) in Q1 2023, closing a stake of 1,148 shares — an estimated $14K sold.

Alpine Global Management first reported a position in TIL in Q4 2022 and held it in 1 quarter. The position peaked at $14K in Q4 2022. 73 funds tracked by Wall St. Rank hold TIL as of Q1 2023.

Alpine Global Management reported no remaining Instil Bio position as of Q1 2023 after selling out during the quarter.
Alpine Global Management sold 1,148 Instil Bio shares in Q1 2023, an estimated $14K.
Alpine Global Management first reported a position in Instil Bio in Q4 2022 and held it in 1 quarter.
Alpine Global Management's Instil Bio position peaked at $14K in Q4 2022.
73 funds tracked by Wall St. Rank held Instil Bio as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.